133 related articles for article (PubMed ID: 17920697)
1. Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.
Stuart R; Lovett-Racke AE; Frohman EM; Hawker K; Racke MK
J Neuroimmunol; 2007 Nov; 191(1-2):45-50. PubMed ID: 17920697
[TBL] [Abstract][Full Text] [Related]
2. Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.
Teutsch SM; Booth DR; Bennetts BH; Heard RN; Stewart GJ
J Neuroimmunol; 2004 Mar; 148(1-2):218-30. PubMed ID: 14975605
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians].
Andreevskiĭ TV; Sudomoina MA; Gusev EI; Boĭko AN; Alekseenkov AD; Favorova OO
Mol Biol (Mosk); 2002; 36(4):643-8. PubMed ID: 12173468
[TBL] [Abstract][Full Text] [Related]
4. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism.
Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A
Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809
[TBL] [Abstract][Full Text] [Related]
5. CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis.
Mäurer M; Ponath A; Kruse N; Rieckmann P
J Neuroimmunol; 2002 Oct; 131(1-2):213-5. PubMed ID: 12458055
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region.
Boćko D; Bilińska M; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Gruszka E; Frydecka I
Arch Immunol Ther Exp (Warsz); 2003; 51(3):201-5. PubMed ID: 12894875
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD152 (CTLA-4) in children with autoimmune thyroiditis and +49 A/G polymorphism of exon 1 of the CTLA-4 gene.
Kucharska AM; Gorska E; Wasik M; Pyrzak B; Demkow U
J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():77-80. PubMed ID: 20134044
[TBL] [Abstract][Full Text] [Related]
8. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.
Heggarty S; Suppiah V; Silversides J; O'doherty C; Droogan A; McDonnell G; Hawkins S; Graham C; Vandenbroeck K
J Neuroimmunol; 2007 Jul; 187(1-2):187-91. PubMed ID: 17524498
[TBL] [Abstract][Full Text] [Related]
9. Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients.
Rajaee A; Ebrahimi A; Ghiam AF; Kalantari T; Ghaderi A
Rheumatol Int; 2006 Jun; 26(8):687-92. PubMed ID: 16189655
[TBL] [Abstract][Full Text] [Related]
10. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis.
Harbo HF; Celius EG; Vartdal F; Spurkland A
Tissue Antigens; 1999 Jan; 53(1):106-10. PubMed ID: 10082437
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population.
Jun TY; Pae CU; Chae JH; Bahk WM; Kim KS; Han H
Psychiatry Res; 2002 May; 110(1):19-25. PubMed ID: 12007590
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms.
Ligers A; Teleshova N; Masterman T; Huang WX; Hillert J
Genes Immun; 2001 May; 2(3):145-52. PubMed ID: 11426323
[TBL] [Abstract][Full Text] [Related]
13. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
Alizadeh M; Babron MC; Birebent B; Matsuda F; Quelvennec E; Liblau R; Cournu-Rebeix I; Momigliano-Richiardi P; Sequeiros J; Yaouanq J; Genin E; Vasilescu A; Bougerie H; Trojano M; Martins Silva B; Maciel P; Clerget-Darpoux F; Clanet M; Edan G; Fontaine B; Semana G
Ann Neurol; 2003 Jul; 54(1):119-22. PubMed ID: 12838528
[TBL] [Abstract][Full Text] [Related]
14. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis.
Bagos PG; Karnaouri AC; Nikolopoulos GK; Hamodrakas SJ
Mult Scler; 2007 Mar; 13(2):156-68. PubMed ID: 17439880
[TBL] [Abstract][Full Text] [Related]
15. Association of the A/G polymorphism at position 49 in exon 1 of CTLA-4 with the susceptibility to unexplained recurrent spontaneous abortion in the Chinese population.
Wang X; Lin Q; Ma Z; Hong Y; Zhao A; Di W; Lu P
Am J Reprod Immunol; 2005 Feb; 53(2):100-5. PubMed ID: 15790344
[TBL] [Abstract][Full Text] [Related]
16. [The frequency of CTLA-4 gene polymorphism at position 49 exon 1 in children with Hashimoto's thyroiditis].
Kucharska A; Wiśniewska A; Rymkiewicz-Kluczyńska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):163-6. PubMed ID: 17020648
[TBL] [Abstract][Full Text] [Related]
17. CTLA4 dimorphisms and the multiple sclerosis phenotype.
Masterman T; Ligers A; Zhang Z; Hellgren D; Salter H; Anvret M; Hillert J
J Neuroimmunol; 2002 Oct; 131(1-2):208-12. PubMed ID: 12458054
[TBL] [Abstract][Full Text] [Related]
18. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis.
McDonnell GV; Mawhinney H; Graham CA; Hawkins SA; Middleton D
J Neurol Sci; 1999 May; 165(1):77-83. PubMed ID: 10426152
[TBL] [Abstract][Full Text] [Related]
19. [Relationship of CTLA-4 exon 1 A49-->G polymorphism with sCTLA-4 and Th1/Th2 bias in idiopathic dilated cardiomyopathy].
Liu W; Li WM; Gao C; Wang XR; Li DM; Sun NL
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3221-4. PubMed ID: 16405845
[TBL] [Abstract][Full Text] [Related]
20. The CTLA-4 gene is associated with multiple sclerosis.
Ligers A; Xu C; Saarinen S; Hillert J; Olerup O
J Neuroimmunol; 1999 Jun; 97(1-2):182-90. PubMed ID: 10408973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
